Concepedia

Publication | Closed Access

Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial

DOI

160

Citations

15

References

2002

Year

Martin E. Blackstein, C. L. Vogel, Roy M. Ambinder, Jay Cowan, José Iglesias, Allen S. Melemed
Oncology

Abstract

Single-agent gemcitabine is active and well tolerated as first-line treatment in patients with MBC.

References

YearCitations

Page 1